Hydroxychloroquine in COVID-19 Patients

Samah Lutfy

Status and phase: Unknown; Phase 2

Conditions: COVID-19

Treatments: Drug: Hydroxychloroquine

Study type: Interventional

Funder types: Other

Identifiers

NCT04394442

SNH1352020

Details and patient eligibility

About

Many reports argued about the possible beneficial effects of Hydroxychloroquine in treating COVID-19 patients and this study was designed to investigate this claim

Enrollment: 200 estimated patients

Sex: All

Ages: 18 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Confirmed cases of SARS-CoV-2 by PCR

Exclusion criteria

less than 18 years old known hypersensitivity to the drug

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

200 participants in 2 patient groups

Hydroxycholoroquine group

Experimental group

Treatment:

Drug: Hydroxychloroquine

Control group

No Intervention group